Dakota Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Dakota Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,390	Closed	-$411K	–	672
2023 Q1	$411K	Sell	5,390 -2,372	-31%	-$197K	0.03%	402
2022 Q4	$644K	Buy	7,762 +117	+2%	+$9.47K	0.05%	303
2022 Q3	$606K	Buy	+7,645	New	+$645K	0.05%	306
2021 Q3	–	Sell	-2,177	Closed	-$295K	–	370
2021 Q2	$295K	Buy	+2,177	New	+$286K	0.04%	282

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Dakota Wealth Management's XBI Position: Q2 2023 in Review

Dakota Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 5,390 shares — an estimated $411K sold.

Dakota Wealth Management first reported a position in XBI in Q2 2021 and held it in 4 quarters. The position peaked at $644K in Q4 2022. 713 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Dakota Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Dakota Wealth Management sold 5,390 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $411K.
Dakota Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and held it in 4 quarters.
Dakota Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $644K in Q4 2022.
713 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Dakota Wealth Management's 13F filing for Q2 2023, filed 31 Jul 2023.